(Q24245012)

2

0 references

J Deeks

3

0 references

B Delaney

4

0 references

A Harris

5

0 references

M Innes

6

0 references

R Oakes

7

0 references

S Wilson

8

0 references

A Roalfe

9

0 references

C Bennett

10

0 references

D Forman

Cochrane Database of Systematic Reviews

11

0 references

publication date

24 January 2005

0 references

published in

0 references

cites work

Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 months' follow up. The Optimal Regimen Cures Helicobacter Induced Dyspepsia (ORCHID) Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002096.PUB2

Cost effectiveness of screening for and eradication of Helicobacter pylori in young patients with dyspepsia. Comparison groups were not clear in study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002096.PUB2

Helicobacter gastroduodenitis: a serious infectious disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002096.PUB2

Is Helicobacter pylori associated with non-ulcer dyspepsia and will eradication improve symptoms? A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002096.PUB2

Therapy for Helicobacter pylori in patients with nonulcer dyspepsia. A meta-analysis of randomized, controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002096.PUB2

Eradication of Helicobacter pylori in functional dyspepsia. Study had several weaknesses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002096.PUB2

Lack of effect of treatment for Helicobacter pylori on symptoms of nonulcer dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002096.PUB2

7 January 2021

Bismuth subsalicylate suppression of Helicobacter pylori in nonulcer dyspepsia: a double-blind placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002096.PUB2

7 January 2021

Nitrofurans in the treatment of gastritis associated with Campylobacter pylori. The Gastrointestinal Physiology Working Group of Cayetano Heredia and The Johns Hopkins Universities.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002096.PUB2

7 January 2021

A critique of therapeutic trials in Helicobacter pylori-positive functional dyspepsia.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002096.PUB2

7 January 2021

Dyspepsia in general practice: psychological findings in relation to Helicobacter pylori serum antibodies

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002096.PUB2

7 January 2021

Absence of symptomatic benefit of lansoprazole, clarithromycin, and amoxicillin triple therapy in eradication of Helicobacter pylori positive, functional (nonulcer) dyspepsia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002096.PUB2

7 January 2021

Antacids reduce Campylobacter pylori colonization without healing the gastritis in patients with nonulcer dyspepsia and erosive prepyloric changes

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002096.PUB2

7 January 2021

Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002096.PUB2

7 January 2021

What role does Helicobacter pylori play in dyspepsia and nonulcer dyspepsia? Arguments for and against H. pylori being associated with dyspeptic symptoms.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002096.PUB2

7 January 2021

Does endoscopy have a positive impact on quality of life in dyspepsia?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002096.PUB2

7 January 2021

Helicobacter pylori and symptomatic relapse of gastro-oesophageal reflux disease: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002096.PUB2

7 January 2021

Eradication of Helicobacter pylori and non-ulcer dyspepsia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002096.PUB2

7 January 2021

Do young patients with dyspepsia need investigation?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002096.PUB2

7 January 2021

Pretreatment gastric histology is helpful to predict the symptomatic response after H. pylori eradication in patients with nonulcer dyspepsia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002096.PUB2

7 January 2021

Helicobacter pylori-positive functional dyspepsia in elderly patients: comparison of two treatments

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002096.PUB2

7 January 2021

Review article: symptom improvement through eradication of Helicobacter pylori in patients with non-ulcer dyspepsia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002096.PUB2

7 January 2021

Cure of Helicobacter pylori infection does not improve symptoms in non-ulcer dyspepsia patients-a double-blind placebo-controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002096.PUB2

7 January 2021

Eradication of Helicobacter pylori prevents ulcer development in patients with ulcer-like functional dyspepsia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002096.PUB2

7 January 2021

There are some benefits for eradicating Helicobacter pylori in patients with non-ulcer dyspepsia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002096.PUB2

7 January 2021

Clinical and pathological implications of IgG antibody responses to Helicobacter pylori and its virulence factors in non-ulcer dyspepsia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002096.PUB2

7 January 2021

The long-term effect of Helicobacter pylori eradication therapy on symptoms in dyspeptic patients with fundic atrophic gastritis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002096.PUB2

7 January 2021

Role of anti-Helicobacter pylori treatment in H. pylori-positive and cytoprotective drugs in H. pylori-negative, non-ulcer dyspepsia: results of a randomized, double-blind, controlled trial in Asian Indians

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002096.PUB2

7 January 2021

Helicobacter pylori eradication does not exacerbate reflux symptoms in gastroesophageal reflux disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002096.PUB2

7 January 2021

Healing of benign gastric ulcer with low-dose antacid or cimetidine. A double-blind, randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002096.PUB2

7 January 2021

Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002096.PUB2

7 January 2021

Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002096.PUB2

7 January 2021

Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002096.PUB2

7 January 2021

In dyspeptic patients without gastric phase III of the migrating motor complex, Helicobacter pylori eradication produces no short-term changes in interdigestive motility pattern

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002096.PUB2

7 January 2021

Effects of Helicobacter pylori eradication on gastric function indices in functional dyspepsia. A prospective controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002096.PUB2

7 January 2021

Bismuth subsalicylate in the treatment of gastritis due to Campylobacter pylori

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002096.PUB2

7 January 2021

Are routine duodenal and antral biopsies useful in the management of "functional" dyspepsia? A diagnostic and therapeutic study.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002096.PUB2

7 January 2021

Helicobacter pylori clearance in the treatment of non-ulcer dyspepsia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002096.PUB2

7 January 2021

Review article: functional dyspepsia—should treatment be targeted on disturbed physiology?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002096.PUB2

7 January 2021

A survey of dyspepsia in Great Britain

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002096.PUB2

7 January 2021

Lansoprazole and amoxycillin: observations on the treatment of Helicobacter pylori infection

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002096.PUB2

7 January 2021

Helicobacter pylori eradication treatment does not benefit patients with nonulcer dyspepsia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002096.PUB2

7 January 2021

An update of the Cochrane systematic review of Helicobacter pylori eradication therapy in nonulcer dyspepsia: resolving the discrepancy between systematic reviews.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002096.PUB2

7 January 2021

Endoscopic studies of dyspepsia in a general practice.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002096.PUB2

7 January 2021

Eradicating Helicobacter pylori and symptoms of non-ulcer dyspepsia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002096.PUB2

7 January 2021

Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia. Dyspepsia Review Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002096.PUB2

7 January 2021

Non-ulcer dyspepsia and short term De-Nol therapy: a placebo controlled trial with particular reference to the role of Campylobacter pylori

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002096.PUB2

7 January 2021

Effect of treatment on Campylobacter pylori in peptic disease: a randomised prospective trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002096.PUB2

7 January 2021

Campylobacter associated gastritis in patients with non-ulcer dyspepsia: a double blind placebo controlled trial with colloidal bismuth subcitrate

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002096.PUB2

7 January 2021

Dyspepsia in England and Scotland

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002096.PUB2

7 January 2021

Effect of colloidal bismuth subcitrate on symptoms and gastric histology in non-ulcer dyspepsia. A double blind placebo controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002096.PUB2

7 January 2021

A substantial proportion of non-ulcer dyspepsia patients have the same abnormality of acid secretion as duodenal ulcer patients

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002096.PUB2

7 January 2021

Does Helicobacter pylori infection increase gastric sensitivity in functional dyspepsia?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002096.PUB2

7 January 2021

Studies of the epidemiology of peptic ulcer in a rural community: prevalence and natural history of dyspepsia and peptic ulcer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002096.PUB2

7 January 2021

Gastric epithelium in the duodenum: its association with Helicobacter pylori and inflammation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002096.PUB2

7 January 2021

Bismuth-based triple therapy with bismuth subcitrate, metronidazole and tetracycline in the eradication of Helicobacter pylori: a randomized, placebo controlled, double-blind study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002096.PUB2

7 January 2021

Effect of Helicobacter pylori eradication or of ranitidine plus metoclopramide on Helicobacter pylori-positive functional dyspepsia. A randomized, controlled follow-up study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002096.PUB2

7 January 2021

Presence of Helicobacter pylori in patients with non-ulcer dyspepsia revealing normal antral histological characteristics

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002096.PUB2

7 January 2021

Campylobacter pylori and non-ulcer dyspepsia. 1. The final results of a double-blind multicentre trial for treatment with pirenzepine in Italy

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002096.PUB2

7 January 2021

Campylobacter pylori and non-ulcer dyspepsia. 2. A prospective study in a Swedish population

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002096.PUB2

7 January 2021

Does omeprazole improve antimicrobial therapy directed towards gastric Campylobacter pylori in patients with antral gastritis? A pilot study.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002096.PUB2

7 January 2021

Campylobacter pylori--a role in non-ulcer dyspepsia?

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002096.PUB2

7 January 2021

Helicobacter pyloriInfection and Non-Ulcer Dyspepsia: The Effect of Treatment with Colloidal Bismuth Subcitrate

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002096.PUB2

7 January 2021

Distinct profiles of gastritis in dyspepsia subgroups. Their different clinical responses to gastritis healing after Helicobacter pylori eradication

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002096.PUB2

7 January 2021

Eradication of Helicobacter pylori affects symptoms in non-ulcer dyspepsia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002096.PUB2

7 January 2021